News from egalet corporation A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.
Latest
May 16, 2019, 16:02 ET Egalet Reports First Quarter 2019 Financial Results and Plan to Change Company Name to Zyla Life Sciences
Egalet Corporation (OTCQX: ZCOR) ("Egalet"), a growing commercial-stage life sciences company, today reported financial results for the first quarter ...
Nov 19, 2018, 06:02 ET Egalet Reports Third Quarter 2018 Financial Results
Egalet Corporation (Nasdaq: EGLT) ("Egalet"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and marketing...
Oct 31, 2018, 06:04 ET Egalet Signs Asset Purchase Agreement to Acquire Four FDA-Approved, Non-Narcotic Pain Products
Egalet Corporation (OTCQX: EGLT) ("Egalet"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and marketing...
Aug 08, 2018, 06:02 ET Egalet Reports Second Quarter 2018 Financial Results
Egalet Corporation (Nasdaq: EGLT) ("Egalet"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and marketing...
Jul 25, 2018, 06:02 ET Egalet to Host Conference Call and Webcast to Discuss Second Quarter 2018 Financial Results on August 8, 2018
Egalet Corporation (Nasdaq: EGLT) ("Egalet"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and marketing...
Jun 07, 2018, 06:02 ET Egalet Appoints Industry Veteran John Varian to Board of Directors
Egalet Corporation (Nasdaq: EGLT) ("Egalet"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and marketing...
Jun 04, 2018, 06:02 ET Egalet to Participate in Panels at 2018 BIO International Convention and JMP Life Sciences Conference
Egalet Corporation (Nasdaq: EGLT) ("Egalet"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and marketing...
May 29, 2018, 06:02 ET Egalet Announces Large Regional Plan to Cover SPRIX® Nasal Spray
Egalet Corporation (Nasdaq: EGLT) ("Egalet"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and marketing...
May 08, 2018, 06:02 ET Egalet Reports First Quarter 2018 Financial Results
Egalet Corporation (Nasdaq: EGLT) ("Egalet"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and marketing...
May 07, 2018, 06:02 ET Egalet Announces National Pharmacy Benefit Manager to Cover SPRIX® Nasal Spray and ARYMO® ER
Egalet Corporation (Nasdaq: EGLT) ("Egalet"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and marketing...
Apr 30, 2018, 06:02 ET Egalet Presented Data at American Academy of Pain Medicine Examining the Potential of ARYMO® ER to Deter Opioid Abuse
Egalet Corporation (Nasdaq: EGLT) ("Egalet"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and...
Apr 24, 2018, 06:02 ET Egalet to Host Conference Call and Webcast to Discuss First Quarter 2018 Financial Results on May 8, 2018
Egalet Corporation (Nasdaq: EGLT) ("Egalet"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and marketing...
Mar 21, 2018, 06:02 ET Egalet to Present at Upcoming Conferences
Egalet Corporation (Nasdaq: EGLT) ("Egalet"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and...
Mar 12, 2018, 06:02 ET Egalet Reports Fourth Quarter and Full Year 2017 Financial Results
Egalet Corporation (Nasdaq: EGLT) ("Egalet"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and...
Feb 28, 2018, 06:02 ET Egalet Announces a Large Regional Health Plan Placed ARYMO® ER and SPRIX® Nasal Spray in Preferred Formulary Positions
Egalet Corporation (Nasdaq: EGLT) ("Egalet"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and marketing...
Feb 26, 2018, 04:02 ET Egalet to Host Conference Call and Webcast to Discuss Fourth Quarter and Year-End 2017 Financial Results on March 12, 2018
Egalet Corporation (Nasdaq: EGLT) ("Egalet"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and marketing...
Feb 01, 2018, 06:44 ET Egalet to Participate in Panel at BIO CEO & Investor Conference
Egalet Corporation (Nasdaq: EGLT) ("Egalet"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and marketing...
Jan 29, 2018, 06:02 ET Egalet Announces ARYMO® ER Data Published in Current Medical Research and Opinion Journal
Egalet Corporation (Nasdaq: EGLT) ("Egalet"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and marketing...
Jan 24, 2018, 06:02 ET Egalet to Co-Host Category 1 Focus Group
Egalet Corporation (Nasdaq: EGLT) ("Egalet"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and marketing...
Dec 20, 2017, 07:16 ET Egalet Reduces Debt Obligation, Extends Maturity and Lowers Annual Interest Payments through Refinancing of Existing Convertible Notes
Egalet Corporation (Nasdaq: EGLT) (Egalet), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and...
Dec 15, 2017, 05:02 ET Egalet Receives FDA Tentative Approval for Expanded Label for ARYMO® ER (morphine sulfate) C-II, an Extended-Release Morphine Product Formulated with Abuse-Deterrent Properties for Treatment of Chronic Pain
Egalet Corporation (Nasdaq: EGLT) (Egalet), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and...
Nov 28, 2017, 05:02 ET Egalet Announces Positive Top-Line Results from Phase 3 Study Evaluating Efficacy and Safety of Egalet-002 in Patients with Moderate-to-Severe Chronic Low Back Pain
Egalet Corporation (Nasdaq: EGLT) (Egalet), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and...
Nov 20, 2017, 05:02 ET Egalet Received a Grant from InnoBooster to Develop a Novel Application of Guardian™ Technology
Egalet Corporation (Nasdaq: EGLT) (Egalet), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and...
Nov 16, 2017, 13:50 ET Egalet Announces Positive Top-Line Results from Phase 3 Safety Study Evaluating Safety of Egalet-002
Egalet Corporation (Nasdaq: EGLT) (Egalet), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and...
Nov 08, 2017, 05:02 ET Egalet Announces Third Quarter 2017 Financial Results
Egalet Corporation (Nasdaq: EGLT) (Egalet), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and...
